Cargando…
Epigenetic regulator MLL2 shows altered expression in cancer cell lines and tumors from human breast and colon
BACKGROUND: MLL2, an epigenetic regulator in mammalian cells, mediates histone 3 lysine 4 tri-methylation (H3K4me3) through the formation of a multiprotein complex. MLL2 shares a high degree of structural similarity with MLL, which is frequently disrupted in leukemias via chromosomal translocations....
Autores principales: | Natarajan, Thanemozhi G, Kallakury, Bhaskar V, Sheehan, Christine E, Bartlett, Margaret B, Ganesan, Natarajan, Preet, Anju, Ross, Jeffrey S, FitzGerald, Kevin T |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878298/ https://www.ncbi.nlm.nih.gov/pubmed/20433758 http://dx.doi.org/10.1186/1475-2867-10-13 |
Ejemplares similares
-
MLL2/KMT2D and MLL3/KMT2C expression correlates with disease progression and response to imatinib mesylate in chronic myeloid leukemia
por: Rabello, Doralina do Amaral, et al.
Publicado: (2018) -
Acute-phase serum amyloid A production by rheumatoid arthritis
synovial tissue
por: O'Hara, Rosemary, et al.
Publicado: (2000) -
Anticancer effects of bifidobacteria on colon cancer cell lines
por: Faghfoori, Zeinab, et al.
Publicado: (2021) -
Epigenetic inactivation and aberrant transcription of CSMD1 in squamous cell carcinoma cell lines
por: Richter, Toni M, et al.
Publicado: (2005) -
Molecular and Epigenetic Mechanisms of MLL in Human Leukemogenesis
por: Ballabio, Erica, et al.
Publicado: (2012)